Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy.
about
The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapyOptimized imaging of the midface and orbitsRole of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinomaVisualization, imaging and new preclinical diagnostics in radiation oncology.Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time.Non-invasive imaging of angiogenesis in head and neck squamous cell carcinomaOptimization of perfusion CT protocol for imaging of extracranial head and neck tumors.Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours.Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck.Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesImaging angiogenesis: applications and potential for drug development.Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusionAn approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyAdvanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review.The promise of dynamic contrast-enhanced imaging in radiation therapyEarly prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study.Novel imaging approaches to head and neck cancerWarburg revisited: imaging tumour blood flow and metabolism.Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome.Perfusion-CT monitoring of cryo-ablated renal cells tumors.Diffusion-weighted imaging in head and neck cancers.CT perfusion in oncology: how to do it.Perfusion CT in solid body-tumours. Part II: Clinical applications and future development.Newer imaging techniques in head and neck cancer.Multiparametric PET/CT in oncology.The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Correlations between CT perfusion parameters and vascular endothelial growth factor expression and microvessel density in implanted VX2 lung tumors.Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.Noninvasive diffuse optical monitoring of head and neck tumor blood flow and oxygenation during radiation delivery.Head and neck cancer: how imaging predicts treatment outcome.Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings.An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.
P2860
Q24801373-E13B8E57-A1DC-4C45-B457-FB07224CAE9DQ26771867-1BF51D90-E424-415B-82D8-F3357D4C114BQ26825536-99F21547-81D3-4809-B9B8-20B9B7BCB214Q30725740-5F6027E9-505F-4B11-8083-40B002F97C99Q33796799-EFB1F35F-6AA7-44D2-BE39-979F6B16BE65Q34029591-E4AAB4E4-F91E-4F3A-BEF9-03DC5DD319D7Q34598143-E06B630A-350F-4DAD-A330-0B200341AB76Q34776519-E8E5FC39-E10A-4865-9F41-1ECA0FE8C188Q34810321-A3927556-9651-4CA4-81E8-3597A7B3E7D1Q35034709-BBD0CC10-8FD8-4872-B407-5D5859517540Q35184804-BE873A73-EC7C-4DEC-AE30-8BB6F96816ACQ35202162-F5BF6353-476C-45B7-8337-8BD6B6E4A6E2Q35223964-A0ACB723-AE77-4B9B-BB74-02B8E0C82D8AQ36027611-9457BC21-A19E-413C-8111-13E4E2B0FAF4Q36086448-4CEAEE6F-73E7-4ACE-A9B1-24330D97758CQ36173661-63746C0D-B1E3-407B-BA04-9183BD5EC080Q36416979-B9FC05B2-6FA3-4559-BA41-6D4CF886D517Q36528319-BAD6A9EE-CA77-40A3-AE39-4D65F3C49675Q36747134-72FDE7EC-9D08-4B17-A231-38093B7C21CFQ36802886-53BB422F-6453-43BA-9CA3-C56FE0E8CD2BQ37012938-28AF0747-FA93-429D-B62E-552B8CAA7F5EQ37129062-31F488E4-6BE3-4E64-A373-7A88BD4FCEA9Q37238573-1058CCB7-EAC7-45D3-9435-6A938899F16AQ37392001-691E174D-5F94-4874-9FD7-AFF5AEED6193Q37469917-9CAEF53A-C0F7-442A-BC8A-9D74A9AEDADDQ37693472-E950ACB0-AA52-4F78-BEE8-A86E299FCC00Q37707171-A922D242-7F3C-41EB-8B0F-530F4484E531Q38038842-B4E598C1-C56C-45C9-A6F3-5C838F9C2274Q38047768-459C2F3F-743C-45B0-BCE7-346C7967EEB4Q38114042-8CDAE215-2E08-4727-A972-EF2BABDD75ADQ38198858-A8CB98D2-3029-4AFF-B0A3-A78568CE025EQ38367091-44B47857-A371-4A65-9BDE-9361A0D178C2Q38816759-E2C0CDF8-2A86-4641-9C87-5D833C8382C6Q38836743-93B7F120-1DF2-4BDC-B8F6-2CE618A57ECCQ39000558-D4A1CB31-EE3D-401B-B469-7B4B3B0B829BQ40103521-E2F3BCBB-FAF4-4C5D-80C7-C90BFC5E85D0Q40775637-7CA57BDA-2AD4-459D-B724-B64D44D094F3Q41812046-9C1ADFDE-D5B0-4817-9C2E-0C272228E6ADQ41894700-16B20AC6-5281-4F48-8930-93F1A9CEFD71Q43073836-D3FD13FA-FDC5-43F2-8E3C-41517CCE06AD
P2860
Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@en
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@nl
type
label
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@en
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@nl
prefLabel
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@en
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@nl
P2093
P1476
Tumor perfusion rate determine ...... eck cancer after radiotherapy.
@en
P2093
Alexis Rijnders
Caroline Weltens
Philippe Lambin
Robert Hermans
Walter Van den Bogaert
P304
P356
10.1016/S0360-3016(03)00764-8
P407
P577
2003-12-01T00:00:00Z